Biomimetic Approaches in the Development of Optimised 3D Culture Environments for Drug Discovery in Cardiac Disease
Cardiovascular disease remains the leading cause of death worldwide, yet despite massive investment in drug discovery, the progress of cardiovascular drugs from lab to clinic remains slow. It is a complex, costly pathway from drug discovery to the clinic and failure becomes more expensive as a drug...
Saved in:
| Main Author: | Jenny Shepherd |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Biomimetics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2313-7673/10/4/204 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Three-Dimensional Culture System: A New Frontier in Cancer Research, Drug Discovery, and Stem Cell-Based Therapy
by: Guya Diletta Marconi, et al.
Published: (2025-07-01) -
Cardiac organoids: a new tool for disease modeling and drug screening applications
by: Ahmed Yaqinuddin, et al.
Published: (2025-05-01) -
3D bioprinting for the construction of drug testing models-development strategies and regulatory concerns
by: Divya Mallya, et al.
Published: (2025-02-01) -
3D printing of biomimetic liquid crystal elastomers with enhanced energy absorption capacities
by: Yao zhao, et al.
Published: (2024-11-01) -
Editorial: Multi-target drug discovery and design for complex health disorders
by: Farid A. Badria, et al.
Published: (2025-06-01)